|

Study of Wilms Tumors Among Patients of Shefa Al-Orman Children Cancer Hospital

RECRUITINGSponsored by South Egypt Cancer Institute
Actively Recruiting
SponsorSouth Egypt Cancer Institute
Started2020-06-15
Est. completion2024-06
Eligibility
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06288802

Summary

The goal of this cross sectional observational study is to determine the percentage of Wilms tumors among pediatric cancers at Shefa Al-Orman Children Cancer Hospital from june 2020 to june 2024,to study the outcome of patients with Wilms tumor treated according to SIOP Umbrella protocol during the study period and to study the treatment related complications during therapy according to common terminology criteria of adverse events version 5.0 (CTCAE Version 5.0).

Eligibility

Healthy volunteers accepted
Inclusion Criteria:

* Children and young adolescene younger than 18 years of age admitted and treated at Shefa Al-orman Children Cancer Hospital during the study period

Exclusion Criteria:

* Patients aged older than 18 years old, died early at presentation before starting chemotherapy, patients with non-Wilms renal tumors, relapsed renal tumors.

Conditions2

CancerWilms Tumor

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.